NCT07189117View on ClinicalTrials.gov

Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies

Not yet recruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2040

Conditions
Hematologic Malignancy
Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT07189117 - Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies | Biotech Hunter | Biotech Hunter